WHO ICTRP trial

A 12-Week, Randomised, Double-Blind, Placebo-Controlled, Parallel Group…

EUCTR2009-014586-75-HU · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2009-014586-75-HU
Public title A 12-Week, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multinational, Phase IIb Study to Evaluate the Efficacy and Safety of 60 mg AZD9668 Administered Orally Twice Daily to Subjects with Chronic Obstructive Pulmonary Disease (COPD) on Treatment with budesonide/formoterol - MISTRAL
Scientific title A 12-Week, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multinational, Phase IIb Study to Evaluate the Efficacy and Safety of 60 mg AZD9668 Administered Orally Twice Daily to Subjects with Chronic Obstructive Pulmonary Disease (COPD) on Treatment with budesonide/formoterol - MISTRAL
Primary sponsor AstraZeneca AB
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Hungary;Slovakia;Czech Republic;Bulgaria
Conditions Chronic Obstructive Pulmonary Disease MedDRA version: 12.0 Level: LLT Classification code 10010952 Term: COPD
Interventions Product Name: AZD9668 Product Code: AZD9668 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: none CAS Number: none Current Sponsor code: AZD9668 Concentration unit: mg milligram(s) Concentration type: equal Concentration number…
Registration date Sep 28, 2009
Target size 600
Secondary IDs D0520C00020
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations